Trademark: 79224525
Word
AYOXXA
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2019
Serial Number
79224525
Registration Number
5705785
Registration Date
Tuesday, March 26, 2019
Mark Type
4000
Filing Date
Friday, October 6, 2017
Published for Opposition
Tuesday, January 8, 2019

Trademark Owner History
AyoxxA Biosystems GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; veterinary pharmaceutical preparations for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; chemical and biochemical preparations for medical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical purposes; chemical and biochemical preparations for veterinary purposes, namely, for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; chemical and biochemical reagents for veterinary purposes; chemical and biochemical preparations for pharmaceutical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical or veterinary pharmaceutical purposes; biological agents for laboratory analyses for medical purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for medical purposes; biological agents for laboratory analyses for veterinary purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for veterinary purposes; chemical and biochemical preparations and reagents for medical purposes, namely, for use in DNA analyses; chemical and biochemical preparations for blood tests for medical purposes; chemical and biochemical reagents for blood tests for medical purposes; chemical and biochemical preparations for blood tests for veterinary purposes; chemical and biochemical reagents for blood tests for veterinary purposes; peptides, proteins, nucleic acids and other biomolecules, or complexes of these molecules, for medical purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for the treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases, protein arrays for medical diagnosis purposes, nucleic acid sequences for medical diagnosis purposes; proteins, nucleic acids and other biomolecules, or complexes of these molecules, for veterinary purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations in animals, protein arrays for veterinary diagnosis purposes, nucleic acid sequences for veterinary diagnosis purposes; chemical and biochemical preparations and reagents for labelling of molecules for medical detection and monitoring purposes; chemical and biochemical preparations and reagents for labelling of molecules for veterinary detection and monitoring purposes

Trademark Events
Mar 26, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 1, 2019
New Representative At Ib Received
Aug 16, 2019
Final Decision Transaction Processed By Ib
Jul 25, 2019
Final Disposition Notice Sent To Ib
Jul 25, 2019
Final Disposition Processed
Jun 26, 2019
Final Disposition Notice Created, To Be Sent To Ib
Mar 26, 2019
Registered-Principal Register
Jan 8, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 8, 2019
Published For Opposition
Dec 19, 2018
Notification Of Notice Of Publication E-Mailed
Nov 14, 2018
Approved For Pub - Principal Register
Oct 22, 2018
Assigned To Examiner
Sep 21, 2018
Teas/Email Correspondence Entered
Sep 21, 2018
Correspondence Received In Law Office
Sep 21, 2018
Teas Response To Office Action Received
Apr 6, 2018
Refusal Processed By Ib
Mar 22, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Mar 22, 2018
Refusal Processed By Mpu
Mar 22, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Mar 21, 2018
Non-Final Action Written
Feb 16, 2018
Non-Final Action (Ib Refusal) Withdrawn For Review
Feb 7, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Feb 6, 2018
Non-Final Action Written
Jan 16, 2018
Assigned To Examiner
Jan 16, 2018
Application Filing Receipt Mailed
Jan 10, 2018
New Application Office Supplied Data Entered
Jan 4, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24